Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYCR1 | P32322 | 1/20 | 0.46 |
| ▸ | TRAP1 | Q12931 | 3/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 3/20 | 0.41 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30789000 | 1.00 | PYCR1 (0.46) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| Methane SCHEMBL27753799 | 0.98 | PYCR1 (0.45) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL27753798 | 0.83 | PDPK1 (0.44) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL20560539 | 0.82 | DPP4 (0.40) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL29393338 | 0.79 | PYCR1 (0.47) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL20465750 | 0.79 | PYCR1 (0.47) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL15806743 | 0.79 | PYCR1 (0.47) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL308050 | 0.79 | PYCR1 (0.47) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL31448605 | 0.79 | PYCR1 (0.47) | PYCR1TRAP1HSP90AA1HSP90AB1KDM1A | |
| SCHEMBL1561687 | 0.78 | CYP2A6 (0.35) | PYCR1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067770-A1 | POLYTHIOL COMPOSITION AND OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME | SK PUCORE CO., LTD. (KR) | 2024-02-29 | — | — | US | claimed |
| EP-4209526-A1 | POLYTHIOL COMPOSITION AND OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME | SKC Co., Ltd. (KR) | 2023-07-12 | — | — | EP | claimed |
| CN-115989280-A | Polythiol composition and optical polymerizable composition comprising the same | SKC株式会社 | 2023-04-18 | — | — | CN | claimed |
| CN-119569735-A | Heteroaryl compounds, preparation method thereof and application thereof in medicines | 江苏恒瑞医药股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20250034150-A1 | BTK INHIBITORS | BIOGEN MA INC. | 2025-01-30 | — | — | US | disclosed |
| EP-4429770-A1 | BTK INHIBITORS | Biogen MA Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| EP-3455224-B1 | SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-ONES AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO[2,1-C][1,2,4]TRIAZOL-3-ONES, AND USE THEREOF | BAYER AG (DE) | 2024-03-27 | — | — | EP | disclosed |
| US-20240067770-A1 | POLYTHIOL COMPOSITION AND OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME | SK PUCORE CO., LTD. (KR) | 2024-02-29 | — | — | US | disclosed |
| CN-114029091-B | Dual ligand catalytic system for ethylene selective trimerization, preparation method and application thereof | 浙江智英石化技术有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-4209526-A1 | POLYTHIOL COMPOSITION AND OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME | SKC Co., Ltd. (KR) | 2023-07-12 | — | — | EP | disclosed |
| WO-2023086521-A1 | BTK INHIBITORS | BIOGEN MA INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| CN-100402524-C | Synthesis of 8-(4,6-dimethoxy pyrimidine oxy)-2-substituted phentriazine-1-one derivative and its herbicide activity | HUZHONG NORMAL UNIV (CN) | 2008-07-16 | — | — | CN | disclosed |
| US-20070244148-A1 | Imidazo 4,5-C Pyridine Compounds and Methods of Antiviral Treatment | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2007-10-18 | — | — | US | disclosed |
| US-20070244148-A1 | Imidazo 4,5-C Pyridine Compounds and Methods of Antiviral Treatment | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2007-10-18 | — | — | US | disclosed |
| WO-2007090826-A1 | PIPERIDINE DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-08-16 | — | — | WO | disclosed |
| CN-1903853-A | Synthesis of 8-(4,6-dimethoxy pyrimidine oxy)-2-substituted phentriazine-1-one derivative and its herbicide activity | HUZHONG NORMAL UNIV (CN) | 2007-01-31 | — | — | CN | disclosed |
| CN-1832922-A | Sulfonyl-substituted N- (biarylmethyl) aminocyclopropanecarboxamides | MERCK & CO INC (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1058594-A | Imidazo [4,5-C] pyridines osteoporosis agent | AMERICAN HOME PROD (US) | 1992-02-12 | — | — | CN | disclosed |
| US-5081253-A | IMIDAZO(4,5-C)PYRIDINES AS ANTIOSTEOPOROTIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-01-14 | — | — | US | disclosed |
| EP-0434405-A1 | Imidazo[4,5-c]pyridines as antiosteoporotic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1991-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244148-A1 | Imidazo 4,5-C Pyridine Compounds and Methods of Antiviral Treatment | ZC3HAV1, TPMT, DPP4 | PYCR1 394/4885TRAP1 4352/4885HSP90AA1 4268/4885 |
| US-20250034150-A1 | BTK INHIBITORS | BTK, SYK, LYN | PYCR1 4526/4885TRAP1 3894/4885HSP90AA1 1258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.